vs
BIOLIFE SOLUTIONS INC（BLFS）与康美（CNMD）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是BIOLIFE SOLUTIONS INC的19.9倍（$373.2M vs $18.8M）。BIOLIFE SOLUTIONS INC同比增速更快（24.3% vs 7.9%）。过去两年康美的营收复合增速更高（9.3% vs 1.0%）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
BLFS vs CNMD — 直观对比
营收规模更大
CNMD
是对方的19.9倍
$18.8M
营收增速更快
BLFS
高出16.5%
7.9%
两年增速更快
CNMD
近两年复合增速
1.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $373.2M |
| 净利润 | $11.1M | — |
| 毛利率 | — | 58.5% |
| 营业利润率 | 7.2% | 9.8% |
| 净利率 | 58.9% | — |
| 营收同比 | 24.3% | 7.9% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $0.23 | $0.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSCNMD
| Q4 25 | $18.8M | $373.2M | ||
| Q3 25 | $28.1M | $337.9M | ||
| Q2 25 | $25.4M | $342.3M | ||
| Q1 25 | $23.9M | $321.3M | ||
| Q4 24 | $15.1M | $345.9M | ||
| Q3 24 | $21.4M | $316.7M | ||
| Q2 24 | $19.7M | $332.1M | ||
| Q1 24 | $18.4M | $312.3M |
净利润BLFSCNMD
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | $2.9M | ||
| Q2 25 | $-15.8M | $21.4M | ||
| Q1 25 | $-448.0K | $6.0M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $-1.7M | $49.0M | ||
| Q2 24 | $-20.7M | $30.0M | ||
| Q1 24 | $-10.2M | $19.7M |
毛利率BLFSCNMD
| Q4 25 | — | 58.5% | ||
| Q3 25 | — | 49.2% | ||
| Q2 25 | — | 55.0% | ||
| Q1 25 | — | 55.3% | ||
| Q4 24 | — | 57.3% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 55.3% | ||
| Q1 24 | — | 55.1% |
营业利润率BLFSCNMD
| Q4 25 | 7.2% | 9.8% | ||
| Q3 25 | -0.3% | 3.5% | ||
| Q2 25 | -65.5% | 11.1% | ||
| Q1 25 | -5.1% | 5.0% | ||
| Q4 24 | 3.6% | 15.2% | ||
| Q3 24 | -2.0% | 20.7% | ||
| Q2 24 | -6.6% | 14.2% | ||
| Q1 24 | -17.9% | 11.2% |
净利率BLFSCNMD
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | 0.8% | ||
| Q2 25 | -62.3% | 6.3% | ||
| Q1 25 | -1.9% | 1.9% | ||
| Q4 24 | 82.5% | — | ||
| Q3 24 | -8.0% | 15.5% | ||
| Q2 24 | -105.1% | 9.0% | ||
| Q1 24 | -55.4% | 6.3% |
每股收益（稀释后）BLFSCNMD
| Q4 25 | $0.23 | $0.54 | ||
| Q3 25 | $0.01 | $0.09 | ||
| Q2 25 | $-0.33 | $0.69 | ||
| Q1 25 | $-0.01 | $0.19 | ||
| Q4 24 | $0.27 | $1.09 | ||
| Q3 24 | $-0.04 | $1.57 | ||
| Q2 24 | $-0.45 | $0.96 | ||
| Q1 24 | $-0.22 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | — |
| 总债务越低越好 | $5.0M | $834.2M |
| 股东权益账面价值 | $371.9M | $1.0B |
| 总资产 | $405.9M | $2.3B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资BLFSCNMD
| Q4 25 | $33.0M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $91.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $29.7M | — |
总债务BLFSCNMD
| Q4 25 | $5.0M | $834.2M | ||
| Q3 25 | $7.5M | $853.0M | ||
| Q2 25 | $10.1M | $881.1M | ||
| Q1 25 | $12.9M | $891.4M | ||
| Q4 24 | $15.9M | $905.1M | ||
| Q3 24 | $20.1M | $940.1M | ||
| Q2 24 | $21.1M | $965.2M | ||
| Q1 24 | $24.3M | $990.1M |
股东权益BLFSCNMD
| Q4 25 | $371.9M | $1.0B | ||
| Q3 25 | $353.7M | $1.0B | ||
| Q2 25 | $347.2M | $1.0B | ||
| Q1 25 | $352.6M | $977.6M | ||
| Q4 24 | $348.9M | $962.7M | ||
| Q3 24 | $325.5M | $932.9M | ||
| Q2 24 | $321.4M | $881.8M | ||
| Q1 24 | $333.4M | $854.7M |
总资产BLFSCNMD
| Q4 25 | $405.9M | $2.3B | ||
| Q3 25 | $392.1M | $2.3B | ||
| Q2 25 | $387.2M | $2.3B | ||
| Q1 25 | $395.1M | $2.3B | ||
| Q4 24 | $399.5M | $2.3B | ||
| Q3 24 | $381.7M | $2.3B | ||
| Q2 24 | $375.0M | $2.3B | ||
| Q1 24 | $401.6M | $2.3B |
负债/权益比BLFSCNMD
| Q4 25 | 0.01× | 0.81× | ||
| Q3 25 | 0.02× | 0.85× | ||
| Q2 25 | 0.03× | 0.88× | ||
| Q1 25 | 0.04× | 0.91× | ||
| Q4 24 | 0.05× | 0.94× | ||
| Q3 24 | 0.06× | 1.01× | ||
| Q2 24 | 0.07× | 1.09× | ||
| Q1 24 | 0.07× | 1.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $46.3M |
| 自由现金流经营现金流 - 资本支出 | — | $41.2M |
| 自由现金流率自由现金流/营收 | — | 11.0% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | $150.9M |
8季度趋势，按日历期对齐
经营现金流BLFSCNMD
| Q4 25 | $4.9M | $46.3M | ||
| Q3 25 | $6.1M | $53.7M | ||
| Q2 25 | $7.4M | $29.1M | ||
| Q1 25 | $1.7M | $41.5M | ||
| Q4 24 | $1.6M | $43.3M | ||
| Q3 24 | $4.8M | $51.2M | ||
| Q2 24 | $6.5M | $43.3M | ||
| Q1 24 | $-4.5M | $29.1M |
自由现金流BLFSCNMD
| Q4 25 | — | $41.2M | ||
| Q3 25 | — | $48.5M | ||
| Q2 25 | — | $23.4M | ||
| Q1 25 | — | $37.8M | ||
| Q4 24 | — | $39.3M | ||
| Q3 24 | — | $47.8M | ||
| Q2 24 | — | $39.7M | ||
| Q1 24 | — | $27.1M |
自由现金流率BLFSCNMD
| Q4 25 | — | 11.0% | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | — | 11.8% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 15.1% | ||
| Q2 24 | — | 12.0% | ||
| Q1 24 | — | 8.7% |
资本支出强度BLFSCNMD
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.7% |
现金转化率BLFSCNMD
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | 18.78× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 6.88× | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.44× | ||
| Q1 24 | — | 1.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLFS
暂无分部数据
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
